Clinical News
View All >>How PREPARE Data, SMART Recommendations Alter Modern Asthma Strategy
1 hour ago
By Kevin Kunzmann
Elliot Israel, MD, and Juan Carlos Cardet, MD, MPH, join Lungcast to discuss their latest research into addressing Black and Latinx asthma outcome disparities.
Family History of OSA Contributes to Pathogenesis of the Condition
16 hours ago
By Armand Butera
Patients with a positive family history of OSA tended to be female with more severe OSA based on a higher AHI.
Significant OSA Prevalence in Pediatric Patients with Pulmonary Hypertension
17 hours ago
By Armand Butera
Obstructive sleep apnea has previously been associated with pulmonary hypertension in literature, with investigators citing a “complex and bidirectional relationship” between the 2 conditions.
OSPREY Trial Suggests THN Therapy Effective in Moderate to Severe OSA
17 hours ago
By Armand Butera
Investigators from this ATS session suggested THN therapy could be used to treat OSA, believing in to be “a simpler approach than incumbent technology with no sensor and an easier, proximal electrode implantation”.
Al Rizzo, MD: Detailing the Latest Data on Pulmonary Health from ATS 2022
18 hours ago
By Armand Butera
Dr. Rizzo sits down with HCPLive to discuss the impact of air pollution and allergies on pulmonary health, as well as new research on pulmonary arterial hypertension.
OSPREY Trial Suggests THN Therapy Effective in Moderate to Severe OSA
17 hours ago
By Armand Butera
Investigators from this ATS session suggested THN therapy could be used to treat OSA, believing in to be “a simpler approach than incumbent technology with no sensor and an easier, proximal electrode implantation”.
Severe Asthma Exacerbation Risk Reduced with Combined Albuterol-Budesonide
19 hours ago
By Armand Butera
Research has indicated that a fixed-dose combination of albuterol and budesonide could better reduce the risk of severe asthma exacerbation when compared to albuterol alone.
Sanjiv Chopra, MD: Treatments for NAFLD on the Way
May 14, 2022
By Kenny Walter
Dr. Chopra said an FDA-approved treatment for NAFLD could come in the next 6 months.
Gerald Smetana, MD: Outpatient COVID-19 Treatment Relies on Primary Care Providers
May 13, 2022
By Giuliana Grossi
Dr. Gerald Smetana encourages PCPs to familiarize themselves with the outpatient drug options for managing COVID-19 because of the limited treatment window for administration.
May 15, 2022 4:30 PM
By Armand Butera
May 15, 2022 4:30 PM
By Armand Butera
May 14, 2022 7:03 PM
By Giuliana Grossi
May 14, 2022 6:11 PM
By Kenny Walter
May 13, 2022 8:30 PM
By Kenny Walter
May 13, 2022 8:00 PM
By Giuliana Grossi
May 13, 2022 7:06 PM
By Kevin Kunzmann
May 13, 2022 6:19 PM
By Kenny Walter
May 13, 2022 6:00 PM
By Giuliana Grossi
May 13, 2022 5:00 PM
By Kenny Walter
May 13, 2022 4:11 PM
By Kevin Kunzmann
May 13, 2022 4:00 PM
By Kenny Walter
